A further important trial on the efficacy of COMT inhibition with EN was the FIRST-STEP (Favorability of Immediate-Release Levodopa/Carbidopa vs STalevo Short-Term comparison in Early Parkinson’s disease) study. This evidence concerns the gene COMT and Parkinson disease.